Inspire Medical Systems ROE 2017-2024 | INSP
Current and historical return on equity (ROE) values for Inspire Medical Systems (INSP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Inspire Medical Systems ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.03B | $0.70B | 5.29% |
| 2024-06-30 | $0.01B | $0.64B | 1.02% |
| 2024-03-31 | $-0.02B | $0.59B | -2.86% |
| 2023-12-31 | $-0.02B | $0.57B | -3.91% |
| 2023-09-30 | $-0.03B | $0.54B | -6.36% |
| 2023-06-30 | $-0.04B | $0.53B | -8.20% |
| 2023-03-31 | $-0.04B | $0.51B | -10.13% |
| 2022-12-31 | $-0.05B | $0.50B | -12.69% |
| 2022-09-30 | $-0.05B | $0.47B | -17.38% |
| 2022-06-30 | $-0.04B | $0.23B | -19.09% |
| 2022-03-31 | $-0.04B | $0.23B | -18.79% |
| 2021-12-31 | $-0.04B | $0.23B | -18.39% |
| 2021-09-30 | $-0.05B | $0.22B | -20.60% |
| 2021-06-30 | $-0.05B | $0.22B | -20.40% |
| 2021-03-31 | $-0.06B | $0.22B | -24.45% |
| 2020-12-31 | $-0.06B | $0.23B | -27.32% |
| 2020-09-30 | $-0.06B | $0.23B | -31.78% |
| 2020-06-30 | $-0.06B | $0.23B | -34.62% |
| 2020-03-31 | $-0.04B | $0.13B | -29.03% |
| 2019-12-31 | $-0.03B | $0.14B | -22.18% |
| 2019-09-30 | $-0.03B | $0.15B | -18.74% |
| 2019-06-30 | $-0.03B | $0.15B | -18.21% |
| 2019-03-31 | $-0.02B | $0.16B | -18.39% |
| 2018-12-31 | $-0.02B | $0.16B | -25.56% |
| 2018-09-30 | $-0.02B | $0.10B | -44.67% |
| 2018-06-30 | $-0.02B | $0.10B | -84.85% |
| 2018-03-31 | $-0.02B | $-0.01B | 2000.00% |
| 2017-12-31 | $-0.02B | $0.00B | -6800.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.055B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Enovis (ENOV) | United States | $2.646B | 17.94 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |